Introduction {#H1-1-NOI190068}
============

Healthy sexual function is important for psychosocial well-being^[@noi190068r1],[@noi190068r2]^ and intimate partner relations.^[@noi190068r3],[@noi190068r4]^ *Erectile dysfunction* (ED), defined as the inability to maintain an erection sufficient for sexual activity,^[@noi190068r5]^ and pituitary hormone deficiencies may be long-term sequelae of traumatic brain injury (TBI).^[@noi190068r6]^ A plausible biological mechanism for such effects is trauma-induced pituitary damage, which may lead to insufficiencies in testosterone, growth hormone, or cortisol levels,^[@noi190068r7],[@noi190068r8]^ termed *posttraumatic hypopituitarism*.^[@noi190068r9],[@noi190068r10],[@noi190068r11]^

Studies on sexual function in participants with brain injuries have reported a reduced frequency of intercourse,^[@noi190068r10],[@noi190068r12],[@noi190068r13],[@noi190068r14]^ diminished libido,^[@noi190068r10],[@noi190068r12],[@noi190068r13],[@noi190068r14],[@noi190068r15],[@noi190068r16],[@noi190068r17],[@noi190068r18],[@noi190068r19]^ impaired ability to orgasm,^[@noi190068r10],[@noi190068r12],[@noi190068r13],[@noi190068r18],[@noi190068r19]^ ED,^[@noi190068r6],[@noi190068r10],[@noi190068r13],[@noi190068r14],[@noi190068r15],[@noi190068r17]^ and sexual arousal issues.^[@noi190068r10],[@noi190068r12],[@noi190068r18]^ However, these studies were conducted in clinical settings,^[@noi190068r6],[@noi190068r9],[@noi190068r10],[@noi190068r12],[@noi190068r13],[@noi190068r14],[@noi190068r15],[@noi190068r16],[@noi190068r17],[@noi190068r18],[@noi190068r19]^ many were small (N \< 100)^[@noi190068r9],[@noi190068r13],[@noi190068r14],[@noi190068r15],[@noi190068r17],[@noi190068r19]^ or did not specifically investigate ED.^[@noi190068r12],[@noi190068r16],[@noi190068r18],[@noi190068r19]^ Only 1 large study examined ED subsequent to a single TBI in 73 000 clinical patients and 218 000 controls.^[@noi190068r6]^ Over a 10-year follow-up, the adjusted hazard ratio for ED in patients with TBI was 2.5 compared with participants without injuries, and greater TBI severity was associated with higher risk of ED.^[@noi190068r6]^ However, this study focused only on medically evaluated single head injuries, rendering results less applicable to often underdiagnosed sports-related head traumas.^[@noi190068r20],[@noi190068r21]^ Furthermore, this study did not evaluate dose-response associations with repeated head injuries and lacked covariate data, such as body mass index (BMI; calculated as weight in kilograms divided by height in meters squared).^[@noi190068r22]^

Limited research has been conducted on populations likely to receive repeated head injuries, such as athletes in combative and contact sports or the military. Small studies of professional boxers have found hormone insufficiencies^[@noi190068r23],[@noi190068r24],[@noi190068r25]^ and smaller pituitary volumes^[@noi190068r23]^ when compared with controls. One study of 68 National Football League (NFL) players with poor quality-of-life scores found significant associations between repeated mild head injury and pituitary and sexual dysfunction.^[@noi190068r26]^ Three small studies (all N \< 40) reported that veterans with mild blast-related head injury were more likely to have a pituitary hormone insufficiency compared with civilians and uninjured veterans.^[@noi190068r27],[@noi190068r28],[@noi190068r29]^ Exploring these end points in professional US-style football players could yield new insights given that prior studies were small, looked only at clinically defined single head injuries, were conducted in players with a low quality of life, or were conducted in veterans with blast-related rather than mechanical trauma.

We examined the association between football-related concussion symptoms at the time of football injury and self-reported medication recommendations for low testosterone levels or ED in a large cohort of former professional US-style football players. Because former players are at increased risk for ED comorbidities, such as sleep apnea,^[@noi190068r30],[@noi190068r31]^ cardiometabolic disease,^[@noi190068r32],[@noi190068r33],[@noi190068r34]^ opioid use,^[@noi190068r35]^ depression,^[@noi190068r30],[@noi190068r36],[@noi190068r37],[@noi190068r38],[@noi190068r39],[@noi190068r40],[@noi190068r41]^ obesity,^[@noi190068r30]^ and prior use of performance enhancing drugs,^[@noi190068r42]^ we conducted analyses further adjusted for these factors.

Methods {#H1-2-NOI190068}
=======

Participants {#H2-1-NOI190068}
------------

The Football Players' Health Study (FPHS)^[@noi190068r43]^ recruited men who played for the NFL after 1960, when the adoption of hard plastic helmets was mostly complete. Of the 14 906 player addresses obtained from the NFL Players' Association, 1186 (8.6%) were invalid. Questionnaires were sent to the remaining 13 720 former players, of whom 3506 (25.6%) had responded as of March 2017. The Beth Israel Deaconess Medical Center institutional review board approved this study. Informed written consent was obtained from all participants prior to participation.

Concussion Symptoms {#H2-2-NOI190068}
-------------------

Respondents were asked: "While playing or practicing football, did you experience a blow to the head, neck, or upper body followed by any of the following: headaches, nausea, dizziness, loss of consciousness (LOC), memory problems, disorientation, confusion, seizure, visual problems, or feeling unsteady on your feet?" Response options were: none, once, 2 to 5 times, 6 to 10 times, or 11 times or more for each symptom.

Outcomes {#H2-3-NOI190068}
--------

Respondents were asked "Has a medical provider ever recommended or prescribed medicine for: (1) low testosterone or (2) ED?" An affirmative answer served as an indicator of a history of low testosterone levels or ED, respectively. Participants reporting that a health care clinician had ever recommended or prescribed medication for either outcome were considered cases. Participants were additionally asked whether they currently took medication for low testosterone levels or ED.

Covariates {#H2-4-NOI190068}
----------

Participants chose the category that best described their race/ethnicity and were categorized by investigators as black, white, or other. Football position may be a proxy for training regimen, nutrition, and other unmeasured variables and has been associated with injuries.^[@noi190068r44],[@noi190068r45],[@noi190068r46],[@noi190068r47]^ Respondents provided the position(s) played most frequently, which included defensive back, defensive line, kicker/punter, linebacker, offensive line, quarterback, running back, special teams, tight end, or wide receiver. Respondents who selected "special teams" in addition to strength-based positions (eg, offensive line, defensive line, or tight end) were assigned "special line."^[@noi190068r48]^ Players who selected "special teams" and speed-based positions (eg, running back, wide receiver, defensive back, or linebacker) were assigned to "special speed." For the 1037 players (29.6% of all respondents) who endorsed multiple positions, we assigned the highest-risk position based on mild TBI risk per 100 game positions.^[@noi190068r44]^

Body mass index during professional play was calculated using self-reported height and professional weight (\<25.0, 25.0-30.0, or \>30.0). Participants reported the number of seasons of professional play. For 70 men (2.1%) missing these data, total seasons were calculated using the first and last year of professional play or from Pro-Football Reference (PFR) data.^[@noi190068r49]^ Participants were asked "During your active playing years, did you take any medications or other drugs to help performance?"

Participants were asked whether they had ever been recommended or prescribed medication for hypertension, high cholesterol levels, diabetes, heart failure, heart rhythm issues, and/or pain. They were separately asked if they had received a diagnosis of cancer, sleep apnea, or myocardial infarction or had undergone cardiac surgery. Participants were considered to have a heart condition if they reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery. Self-reported weight and height were used to calculate their current BMI.

Anxious and depressive symptoms over the prior 2 weeks were assessed using the Patient Health Questionnaire 4. Responses were separately summed for anxious and depressive symptoms and dichotomized at more than 3 to indicate high depressive or anxiety symptoms.^[@noi190068r50],[@noi190068r51]^ Participants were considered to have depression or anxiety if they reported high symptoms or were currently prescribed antidepressants or anxiolytics, respectively. Alcohol intake was quantified as the total number of alcohol beverages consumed per week.

Statistical Analyses {#H2-5-NOI190068}
--------------------

We calculated the mean age, number of seasons, start year, and end year for study participants. To examine selection bias, we used PFR data to compare the FPHS cohort with all former players who played after 1960. Two-sample *t* tests and χ^2^ tests were used to identify differences between the FPHS and PFR.

Concussion symptom frequency responses of none, once, 2 to 5 times, 6 to 10 times, or 11 or more were coded as 0, 1, 3.5, 8, and 13, respectively, and then summed to create a concussion symptom score. This score was then divided into quartiles to minimize the influence of outliers. Participants who did not respond to more than 5 concussion symptoms were excluded (n = 97). Of the 3409 remaining participants, 1 or more missing symptoms were imputed for 365 players (10.7%) via multiple imputation using chained equations.^[@noi190068r52]^ Thirty-nine participants (1.1%) who did not respond to the LOC question were excluded from models examining LOC as the exposure. Data from participants who did not respond to outcome questions were excluded from related analyses (low testosterone levels, N~missing~ = 75 \[2.2%\]; ED, N~missing~ = 77 \[2.3%\]). Multiple imputation was used for covariates with missing data (N~missing~ = 3 to 88).

To determine whether indicators of low testosterone levels and ED were more prevalent among men with established low testosterone levels and ED risk factors (eg, diabetes), we examined associations between risk factors and outcomes in age- and race-adjusted models. To measure the association of concussion symptom scores with indicators of low testosterone levels and ED, we calculated odds ratios (ORs) separately for indicators of low testosterone levels and ED as the dependent variable and concussion symptoms as the independent variable after adjusting for age and race. Models were further adjusted for football exposures and current health factors in exploratory analyses. To address the possibility that recall bias may have affected the number of reported concussion symptoms, we used LOC as a more easily recalled exposure.^[@noi190068r53],[@noi190068r54]^ To test for linear trends, the median of the concussion symptom quartile or LOC category was assigned to each participant and entered in models as a continuous variable. We additionally examined concussion scores and LOC as continuous measures. To determine whether current health factors statistically mediated associations between concussion scores and low testosterone levels or ED, we fit fully adjusted models with and without each current health factor. We calculated the percentage mediation for each variable as: 100\*(\[β~without\ mediator~-- β~with\ mediator~\]/β~without\ mediator~).

To increase the likelihood that we were capturing men with low testosterone levels and ED, we separately considered only the subset of men who reported currently taking medication for low testosterone levels or ED as cases, excluding men who reported a history of medication recommendation or prescription but no current use. We next examined associations in younger players by restricting the data set to men 50 years or younger. We also restricted the data set to men who last played 20 years or fewer before the survey to determine whether concussion symptoms experienced 2 or more decades prior were associated with the outcomes. Depression and anxiety can lead to ED,^[@noi190068r55],[@noi190068r56],[@noi190068r57]^ and low testosterone levels^[@noi190068r58]^ and ED^[@noi190068r59],[@noi190068r60]^ may cause or exacerbate depression. We therefore included indicators of depression and anxiety in sensitivity analyses. To address the possibility that stigma associated with ED was associated with the response rate, we ran analyses in which all ED nonrespondents were imputed as either "no ED" or "have ED."

We used inverse probability weighting^[@noi190068r61]^ to account for possible selection bias from nonparticipation in the FPHS. We predicted the probability of participation in the FPHS based on position, BMI, career length, and first and last year of professional play using PFR data. The inverse of these probabilities, stabilized and truncated at the 5th and 95th percentiles to minimize the effect of outliers, were used as weights in fully adjusted models of low testosterone levels and ED.^[@noi190068r49],[@noi190068r61]^ Odds ratios for all analyses were estimated using generalized linear models ("glm" package; R Statistical Software; R Foundation) and statistical significance was set at *P *\< .05.

Results {#H1-3-NOI190068}
=======

[Table 1](#noi190068t1){ref-type="table"} shows the distribution of demographic, football, and current health-related variables by concussion symptom quartile. Participants' mean (SD) age was 52.5 (14.1) years. Participants had played a mean (SD) of 6.8 (3.8) seasons. Respondents of the FPHS began their careers 4 years earlier than nonrespondents, ended their careers 3 years earlier, and had slightly longer careers (career start: *t* =  13.1; 95% CI, 3.2-4.4; career end: *t* = 9.3; 95% CI, 2.1-3.2; career duration: *t* = 14.3; 95% CI, −1.3 to −1.0; *P* \< .001 for all). Playing position differed among respondents vs nonrespondents (offensive linemen: FPHS, 21.7%; nonrespondents, 3.6%; χ^2^ = 100.9; *P* \< .001; defensive backs: FPHS, 14.8%; nonrespondents, 9.9%; χ^2^ = 40.7; *P* \< .001; running backs: FPHS, 9.4%; nonrespondents, 13.3%; χ^2^ = 32.3; *P* \< .001; tight ends: FPHS, 7.7%; nonrespondents, 5.9%; χ^2^ = 11.7; *P* \< .001; wide receivers: FPHS, 0.5%; nonrespondents, 12.4%; χ^2^ = 7.9; *P* \< .001).

###### Demographic, Football, and Current Health Factors by Concussion Symptom Quartile for 3409 Participants

  Quartile (Concussion Score Range)                                                   Concussion Symptom Quartile, No. (%)                             
  ----------------------------------------------------------------------------------- -------------------------------------- ------------ ------------ ------------
  No.                                                                                 853 (25.0)                             852 (25.0)   852 (25.0)   852 (25.0)
  **Demographic Factors**                                                                                                                              
  Age, y                                                                                                                                               
  21-40                                                                               202 (23.7)                             198 (23.2)   228 (26.8)   240 (28.2)
  41-60                                                                               308 (36.1)                             341 (40.0)   398 (46.7)   416 (48.8)
  \>60                                                                                343 (40.2)                             313 (36.7)   226 (26.5)   196 (23.0)
  Race/ethnicity                                                                                                                                       
  Black                                                                               310 (36.6)                             286 (34.2)   347 (41.2)   331 (39.1)
  White                                                                               514 (60.8)                             534 (63.9)   479 (56.8)   475 (56.1)
  Other                                                                               22 (2.6)                               16 (1.9)     17 (2.0)     40 (4.7)
  **Football Exposures**                                                                                                                               
  BMI while playing professional football[^a^](#noi190068t1n1){ref-type="table-fn"}                                                                    
  \<25.0                                                                              63 (7.4)                               36 (4.2)     49 (5.8)     39 (4.6)
  25.0-30.0                                                                           427 (50.1)                             404 (47.4)   379 (44.5)   322 (37.8)
  \>30.0                                                                              363 (42.6)                             412 (48.4)   423 (49.6)   491 (57.6)
  Professional use of PED                                                             87 (10.2)                              99 (11.6)    135 (15.8)   229 (26.9)
  Position                                                                                                                                             
  Defensive back                                                                      117 (13.7)                             118 (13.8)   142 (16.7)   122 (14.3)
  Defensive line                                                                      104 (12.2)                             83 (9.7)     82 (9.6)     100 (11.7)
  Kicker/punter                                                                       61 (7.2)                               23 (2.7)     14 (1.6)     6 (0.7)
  Linebacker                                                                          81 (9.5)                               79 (9.3)     86 (10.1)    113 (13.3)
  Offensive line                                                                      137 (16.1)                             179 (21.0)   155 (18.2)   157 (18.4)
  Quarterback                                                                         51 (6.0)                               58 (6.8)     36 (4.2)     18 (2.1)
  Running back                                                                        70 (8.2)                               68 (8.0)     87 (10.2)    94 (11.0)
  Special teams only                                                                  3 (0.4)                                10 (1.2)     8 (0.9)      6 (0.7)
  Special speed                                                                       20 (2.3)                               34 (4.0)     43 (5.0)     37 (4.3)
  Special strength                                                                    36 (4.2)                               49 (5.8)     48 (5.6)     56 (6.6)
  Tight end                                                                           59 (6.9)                               64 (7.5)     68 (8.0)     71 (8.3)
  Wide receiver                                                                       114 (13.4)                             87 (10.2)    83 (9.7)     72 (8.5)
  Current health-related factors                                                                                                                       
  Hypertension                                                                        322 (37.7)                             306 (35.9)   326 (38.3)   329 (38.6)
  High cholesterol levels                                                             272 (31.9)                             289 (33.9)   309 (36.3)   303 (35.6)
  Diabetes                                                                            60 (7.0)                               92 (10.8)    76 (8.9)     72 (8.5)
  Heart condition[^b^](#noi190068t1n2){ref-type="table-fn"}                           160 (18.8)                             170 (20.0)   155 (18.2)   152 (17.8)
  Prescription pain medication                                                        127 (14.9)                             203 (23.8)   280 (32.9)   360 (42.3)
  Prostate or testicular cancer                                                       33 (3.9)                               42 (4.9)     24 (2.8)     33 (3.9)
  Sleep apnea                                                                         127 (14.9)                             178 (20.9)   198 (23.2)   257 (30.2)
  Current BMI[^a^](#noi190068t1n1){ref-type="table-fn"}                                                                                                
  \<25.0                                                                              60 (7.0)                               46 (5.4)     52 (6.1)     20 (2.3)
  25.0-30.0                                                                           388 (45.5)                             372 (43.7)   337 (39.6)   333 (39.1)
  \>30.0                                                                              401 (47.0)                             429 (50.4)   457 (53.6)   494 (58.0)
  Mood indicators                                                                                                                                      
  Anxiety only                                                                        28 (3.3)                               42 (4.9)     68 (8.0)     98 (11.5)
  Depression only                                                                     17 (2.0)                               30 (3.5)     47 (5.5)     45 (5.3)
  Depression and anxiety                                                              26 (3.0)                               68 (8.0)     113 (13.3)   262 (30.8)
  Alcohol drinks per wk                                                                                                                                
  None                                                                                268 (31.4)                             270 (31.7)   253 (29.7)   271 (31.8)
  1-7                                                                                 314 (36.8)                             329 (38.6)   309 (36.3)   314 (36.9)
  8-14                                                                                158 (18.5)                             146 (17.1)   145 (17.0)   137 (16.1)
  ≥15                                                                                 99 (11.6)                              101 (11.9)   134 (15.7)   122 (14.3)

Abbreviations: BMI, body mass index; PED, performance-enhancing drugs.

Calculated as weight in kilograms divided by height in meters squared.

Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.

Of 3409 participants, 611 (18.3%) reported indicators of low testosterone levels, and 755 (22.7%) reported indicators of ED. Fewer than 10% of participants reported indicators of low testosterone levels and ED (335 \[9.8%\]). Of 611 players with low testosterone indicators, 243 (39.8%) were currently taking medication. Among players with indicators of ED, half were currently taking medication (379 \[50.2%\]). The prevalence of indicators of low testosterone levels and ED was greater in men with established risk factors ([Table 2](#noi190068t2){ref-type="table"}). In models that included age and race, indicators of low testosterone levels and ED were significantly associated with hypertension, high cholesterol levels, diabetes, heart conditions, prescription pain medication, reproductive cancer, sleep apnea, obesity, and mood disorders ([Table 3](#noi190068t3){ref-type="table"}).

###### Prevalence of History of Low Testosterone Levels and Erectile Dysfunction Indicators by Demographic, Football, and Current Health Factors for 3409 Participants

  Characteristic                                                                      No.    Prevalence of History of Prescription Recommendation by Self-report, No. (%)   
  ----------------------------------------------------------------------------------- ------ ------------------------------------------------------------------------------ ------------
  All                                                                                        611 (18.3)                                                                     755 (22.7)
  **Demographic Factors**                                                                                                                                                   
  Age, y                                                                                                                                                                    
  21-40                                                                               868    70 (8.2)                                                                       46 (5.4)
  41-60                                                                               1463   301 (20.9)                                                                     307 (21.4)
  \>60                                                                                1078   240 (23.1)                                                                     402 (38.6)
  Race                                                                                                                                                                      
  Black                                                                               1274   210 (16.8)                                                                     280 (22.5)
  White                                                                               2002   373 (19.1)                                                                     454 (23.2)
  Other                                                                               95     23 (24.2)                                                                      14 (15.2)
  Missing                                                                             38     5 (13.5)                                                                       7 (18.9)
  **Football Exposures**                                                                                                                                                    
  BMI while playing professional football[^a^](#noi190068t2n1){ref-type="table-fn"}                                                                                         
  \<25.0                                                                              187    33 (17.7)                                                                      36 (19.9)
  25.0-30.0                                                                           1532   243 (16.3)                                                                     353 (23.6)
  \>30.0                                                                              1689   334 (20.2)                                                                     365 (22.0)
  Professional use of PED                                                                                                                                                   
  No                                                                                  2859   471 (16.8)                                                                     608 (21.8)
  Yes                                                                                 550    140 (26.1)                                                                     147 (27.3)
  **Current Health-Related Factors**                                                                                                                                        
  Hypertension                                                                                                                                                              
  No                                                                                  2083   287 (13.9)                                                                     297 (14.5)
  Yes                                                                                 1283   318 (25.5)                                                                     450 (35.9)
  High cholesterol levels                                                                                                                                                   
  No                                                                                  2165   292 (13.7)                                                                     352 (16.5)
  Yes                                                                                 1173   309 (27.0)                                                                     387 (33.6)
  Diabetes                                                                                                                                                                  
  No                                                                                  3021   504 (16.9)                                                                     596 (20.0)
  Yes                                                                                 300    95 (32.5)                                                                      136 (46.7)
  Heart condition[^b^](#noi190068t2n2){ref-type="table-fn"}                                                                                                                 
  No                                                                                  2772   437 (16.0)                                                                     522 (19.2)
  Yes                                                                                 637    174 (28.5)                                                                     233 (37.8)
  Prescription pain medication                                                                                                                                              
  No                                                                                  2439   328 (13.7)                                                                     415 (17.4)
  Yes                                                                                 970    283 (29.9)                                                                     340 (35.7)
  Prostate or testicular cancer                                                                                                                                             
  No                                                                                  3277   576 (18)                                                                       686 (21.4)
  Yes                                                                                 132    35 (27.1)                                                                      69 (54.3)
  Sleep apnea                                                                                                                                                               
  No                                                                                  2582   367 (14.5)                                                                     478 (18.8)
  Yes                                                                                 760    236 (31.9)                                                                     264 (35.7)
  Current BMI[^a^](#noi190068t2n1){ref-type="table-fn"}                                                                                                                     
  \<25.0                                                                              178    16 (9.1)                                                                       32 (18.4)
  25.0-30.0                                                                           1430   211 (15.1)                                                                     276 (19.8)
  \>30.0                                                                              1781   383 (22.0)                                                                     442 (25.4)
  Mood indicators[^c^](#noi190068t2n3){ref-type="table-fn"}                                                                                                                 
  No depression or anxiety                                                            2562   357 (14.3)                                                                     479 (19.1)
  Anxiety only                                                                        236    44 (19.0)                                                                      49 (21.2)
  Depression only                                                                     139    36 (26.5)                                                                      43 (31.9)
  Depression and anxiety                                                              469    174 (37.8)                                                                     184 (40)
  Alcohol drinks per wk                                                                                                                                                     
  None                                                                                1062   213 (20.5)                                                                     240 (23.1)
  1-7                                                                                 1266   210 (17.0)                                                                     266 (21.5)
  8-14                                                                                586    97 (17.0)                                                                      128 (22.1)
  ≥15                                                                                 456    85 (19.0)                                                                      111 (24.8)

Abbreviations: BMI, body mass index; PED, performance-enhancing drugs.

Calculated as weight in kilograms divided by height in meters squared.

Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.

Derived from Patient Health Questionnaire 4.

###### Low Testosterone Levels or ED Indicators in Association With Established Low Testosterone Levels and ED Risk Factors for 3409 Participants

  Characteristic                                                       Prevalence of History of Prescription Recommendation by Self-report, OR (95% CI)   
  -------------------------------------------------------------------- ---------------------------------------------------------------------------------- --------------------------------------------------------------
  **Model 1: Mutually Adjusted for Age and Race**                                                                                                         
  Age, y                                                                                                                                                  
  21-40                                                                1 \[Reference\]                                                                    1 \[Reference\]
  41-60                                                                2.99 (2.27-3.94)[^a^](#noi190068t3n1){ref-type="table-fn"}                         4.82 (3.49-6.66)[^a^](#noi190068t3n1){ref-type="table-fn"}
  \>60                                                                 3.41 (2.56-4.55)[^a^](#noi190068t3n1){ref-type="table-fn"}                         12.22 (8.79-16.98)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Race/ethnicity                                                                                                                                          
  White                                                                1 \[Reference\]                                                                    1 \[Reference\]
  Black                                                                0.97 (0.80-1.17)                                                                   1.4 (1.17-1.69)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Other                                                                1.61 (0.98-2.64)                                                                   0.87 (0.47-1.59)
  Missing                                                              0.64 (0.25-1.67)                                                                   0.63 (0.27-1.50)
  **Models 2-10: Age and Race Adjusted**                                                                                                                  
  Model 2: hypertension                                                1.81 (1.50-2.19)[^a^](#noi190068t3n1){ref-type="table-fn"}                         2.26 (1.89-2.71)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 3: high cholesterol levels                                     1.96 (1.62-2.37)[^a^](#noi190068t3n1){ref-type="table-fn"}                         1.69 (1.41-2.02)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 4: diabetes                                                    2.04 (1.55-2.69)[^a^](#noi190068t3n1){ref-type="table-fn"}                         2.66 (2.04-3.45)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 5: heart condition[^b^](#noi190068t3n2){ref-type="table-fn"}   1.73 (1.39-2.15)[^a^](#noi190068t3n1){ref-type="table-fn"}                         1.64 (1.34-2.01)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 6: prescription pain medication                                2.53 (2.10-3.05)[^a^](#noi190068t3n1){ref-type="table-fn"}                         2.3 (1.93-2.75)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 7: prostate or testicular cancer                               1.31 (0.87-1.97)                                                                   2.54 (1.75-3.69)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 8: sleep apnea                                                 2.51 (2.07-3.05)[^a^](#noi190068t3n1){ref-type="table-fn"}                         2.04 (1.69-2.46)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 9: current BMI[^c^](#noi190068t3n3){ref-type="table-fn"}                                                                                          
  \<25.0                                                               1 \[Reference\]                                                                    1 \[Reference\]
  25.0-30.0                                                            1.93 (1.13-3.32)[^d^](#noi190068t3n4){ref-type="table-fn"}                         1.35 (0.88-2.06)
  \>30.0                                                               3.11 (1.82-5.30)[^a^](#noi190068t3n1){ref-type="table-fn"}                         1.99 (1.31-3.02)[^e^](#noi190068t3n5){ref-type="table-fn"}
  Model 10: mood disorders                                                                                                                                
  None                                                                 1 \[Reference\]                                                                    1 \[Reference\]
  Anxiety indicators only                                              1.63 (1.14-2.33)[^e^](#noi190068t3n5){ref-type="table-fn"}                         1.59 (1.12-2.26)[^d^](#noi190068t3n4){ref-type="table-fn"}
  Depression indicators only                                           2.22 (1.48-3.34)[^a^](#noi190068t3n1){ref-type="table-fn"}                         2.11 (1.41-3.15)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Depression and anxiety indicators                                    4 (3.19-5.02)[^a^](#noi190068t3n1){ref-type="table-fn"}                            3.37 (2.67-4.24)[^a^](#noi190068t3n1){ref-type="table-fn"}
  Model 11: alcohol drinks per wk                                                                                                                         
  None                                                                 1 \[Reference\]                                                                    1 \[Reference\]
  1-7                                                                  0.84 (0.68-1.05)                                                                   1.03 (0.84-1.27)
  8-14                                                                 0.81 (0.61-1.06)                                                                   0.99 (0.76-1.28)
  15+                                                                  0.94 (0.71-1.26)                                                                   1.27 (0.96-1.67)

Abbreviations: BMI, body mass index; ED, erectile dysfunction; OR, odds ratio.

*P* \< .001.

Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.

Calculated as weight in kilograms divided by height in meters squared.

*P* \< .05.

*P* \< .01.

We found statistically significant, monotonically increasing associations between concussion symptoms and indicators for low testosterone levels and ED in models adjusted for age and race ([Figure](#noi190068f1){ref-type="fig"}; low testosterone OR, 3.49; 95% CI, 2.68-4.56; ED OR, 2.41; 95% CI, 1.87-3.11). In models further adjusted for professional football--related exposures (eg, position, BMI during professional play, and self-reported use of performance enhancing drugs), estimates remained essentially unchanged from age- and race-adjusted models ([Figure](#noi190068f1){ref-type="fig"}; low testosterone OR, 3.38; 95% CI, 2.57-4.45; ED OR, 2.32; 95% CI, 1.78-3.02).

![Association Between Concussion Symptom Quartile and Loss of Consciousness With Low Testosterone and Erectile Dysfunction\
A and B, The lowest quartile served as the reference for all models. The base model is adjusted for age and race/ethnicity; the football exposure model is further adjusted for body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) while playing professional football, position, and use of performance-enhancing drugs; and the fully adjusted model is further adjusted for current BMI, heart condition, diabetes, high cholesterol levels, hypertension, sleep apnea, use of prescription pain medication, alcohol drinks per week, and a history of testicular or prostate cancer. Linear tests of trend were significant (*P *\< .01).](jamaneurol-76-1428-g001){#noi190068f1}

Associations in models further adjusted for current health factors were slightly attenuated but remained statistically significant ([Figure](#noi190068f1){ref-type="fig"}; low testosterone OR, 2.39; 95% CI, 1.79-3.19; ED OR, 1.72; 95% CI, 1.30-2.27). Loss of consciousness was associated with indicators of low testosterone levels and ED in models adjusted for demographics, football exposures, and current risk factors ([Figure](#noi190068f1){ref-type="fig"}). In fully adjusted models with concussion symptoms and LOC coded as continuous variables, both were significantly associated with low testosterone levels and ED (concussion symptoms: low testosterone β = 1.01; 95% CI, 1.01-1.02; *P* ≤ .001; ED β = 1.01; 95% CI, 1.01-1.01; *P* ≤ .001; LOC: low testosterone β = 1.08; 95% CI, 1.04-1.12; *P* ≤ .001; ED β = 1.06; 95% CI, 1.02-1.10; *P* = .001). For low testosterone, men with relatively low concussion scores (the second quartile) had significantly elevated ORs compared with men in the lowest quartile (OR, 1.41; 95% CI, 1.05-1.89; *P* = .02).

The largest statistical mediators of the association between concussion score and the outcomes were current use of prescription pain medication (low testosterone mediation, 7.9%; ED mediation, 20.4%) and sleep apnea (low testosterone mediation, 9.7%; ED mediation, 5.9%). All other current health factors statistically mediated the associations by less than 4%.

Results were similar in analyses restricted to participants currently using low testosterone and ED medication among players younger than 50 years, among players who played 20 years or longer before the study, and in inverse probability--weighted analyses. Further adjustment for mood indicators somewhat attenuated associations ([Table 4](#noi190068t4){ref-type="table"}). We conducted a post hoc analysis to compare associations among men with low testosterone levels only, ED only, and men with both. Associations with concussion symptoms were stronger among men reporting low testosterone levels and ED compared with men reporting only 1 of the 2 outcomes (eTable in the [Supplement](#note-NOI190068-1-s){ref-type="supplementary-material"}; highest concussion quartile vs lowest; men with low testosterone only: OR, 2.66; 95% CI, 1.84-3.83, *P* \< .001; men with ED only: OR, 1.47; 95% CI, 1.06-2.04; *P* = .02; men with both outcomes: OR, 4.95; 95% CI, 3.40-7.22; *P* \< .001).

###### Sensitivity Analyses for Low Testosterone Levels and Erectile Dysfunction Indicators for Each Quartile of Concussion Symptom Score for 3409 Participants

  Model                                                                                                       No.                                                           Concussion Symptom Quartile                                  History of Prescription Recommendation, OR (95%)                     
  ----------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------- ----------------- -----------------
  Model 1: base model[^a^](#noi190068t4n1){ref-type="table-fn"}                                               3334                                                          3332                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.62 (1.23-2.15)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.49 (1.15-1.92)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  3                                                                                                           1.97 (1.49-2.6)[^c^](#noi190068t4n3){ref-type="table-fn"}     1.96 (1.53-2.53)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  4                                                                                                           3.49 (2.68-4.56)[^c^](#noi190068t4n3){ref-type="table-fn"}    2.41 (1.87-3.11)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  Model 2: case definition includes only current medication users[^a^](#noi190068t4n1){ref-type="table-fn"}   3334                                                          3332                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.67 (1.10-2.56)[^d^](#noi190068t4n4){ref-type="table-fn"}    1.21 (0.88-1.67)                                                                                                                  
  3                                                                                                           1.93 (1.26-2.94)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.65 (1.21-2.24)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  4                                                                                                           3.02 (2.02-4.5)[^c^](#noi190068t4n3){ref-type="table-fn"}     1.62 (1.18-2.24)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  Model 3: restricted to men ≤50 y[^a^](#noi190068t4n1){ref-type="table-fn"}                                  1460                                                          1457                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.41 (0.84-2.38)                                              1.69 (0.90-3.18)                                                                                                                  
  3                                                                                                           1.72 (1.05-2.83)[^d^](#noi190068t4n4){ref-type="table-fn"}    2.75 (1.53-4.93)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  4                                                                                                           2.92 (1.83-4.66)[^c^](#noi190068t4n3){ref-type="table-fn"}    3.29 (1.85-5.85)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  Model 4: men who last played ≥20 y prior[^a^](#noi190068t4n1){ref-type="table-fn"}                          1953                                                          1953                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.57 (1.14-2.17)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.48 (1.12-1.95)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  3                                                                                                           1.76 (1.27-2.44)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.79 (1.35-2.38)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  4                                                                                                           3.08 (2.24-4.24)[^c^](#noi190068t4n3){ref-type="table-fn"}    2.09 (1.56-2.80)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  Model 5: fully adjusted including mood disorders[^e^](#noi190068t4n5){ref-type="table-fn"}                  3334                                                          3332                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.33 (0.99-1.78)                                              1.19 (0.91-1.56)                                                                                                                  
  3                                                                                                           1.41 (1.05-1. 90)[^d^](#noi190068t4n4){ref-type="table-fn"}   1.43 (1.09-1.88)[^d^](#noi190068t4n4){ref-type="table-fn"}                                                                        
  4                                                                                                           1.89 (1.39-2.55)[^c^](#noi190068t4n3){ref-type="table-fn"}    1.36 (1.02-1.83)[^d^](#noi190068t4n4){ref-type="table-fn"}                                                                        
  Model 6: missing imputed as no[^a^](#noi190068t4n1){ref-type="table-fn"}                                    3409                                                          3409                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.61 (1.22-2.13)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.48 (1.15-1.91)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  3                                                                                                           1.91 (1.45-2.52)[^c^](#noi190068t4n3){ref-type="table-fn"}    1.96 (1.52-2.52)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  4                                                                                                           3.43 (2.63-4.48)[^c^](#noi190068t4n3){ref-type="table-fn"}    2.34 (1.82-3.02)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  Model 7: missing imputed as yes[^a^](#noi190068t4n1){ref-type="table-fn"}                                   3409                                                          3409                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.67 (1.29-2.17)[^c^](#noi190068t4n3){ref-type="table-fn"}    1.51 (1.18-1.92)[^b^](#noi190068t4n2){ref-type="table-fn"}                                                                        
  3                                                                                                           2 (1.54-2.60)[^c^](#noi190068t4n3){ref-type="table-fn"}       1.93 (1.52-2.46)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  4                                                                                                           3.37 (2.61-4.34)[^c^](#noi190068t4n3){ref-type="table-fn"}    2.46 (1.92-3.14)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  Model 8: inverse probability weighted[^e^](#noi190068t4n5){ref-type="table-fn"}                             3334                                                          3332                                                         1                                                  1 \[Reference\]   1 \[Reference\]
  2                                                                                                           1.40 (1.04-1.89)[^d^](#noi190068t4n4){ref-type="table-fn"}    1.34 (1.01-1.77)[^d^](#noi190068t4n4){ref-type="table-fn"}                                                                        
  3                                                                                                           1.50 (1.11-2.03)[^b^](#noi190068t4n2){ref-type="table-fn"}    1.65 (1.25-2.19)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        
  4                                                                                                           2.44 (1.82-3.29)[^c^](#noi190068t4n3){ref-type="table-fn"}    1.90 (1.43-2.54)[^c^](#noi190068t4n3){ref-type="table-fn"}                                                                        

Abbreviation: OR, odds ratio.

Adjusted for age and race.

*P* \< .01.

*P* \< .001.

*P* \< .05.

Adjusted for age, race, professional body mass index (calculated as weight in kilograms divided by height in meters squared), position, use of performance-enhancing drugs, current body mass index, heart condition (eg, heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery), diabetes, high cholesterol levels, hypertension, sleep apnea, alcohol beverages per week, use of prescription pain medication, and history of testicular or prostate cancer.

Discussion {#H1-4-NOI190068}
==========

We identified a highly robust, monotonically increasing association between self-reported concussion symptoms at the time of football injury and self-reported low testosterone levels and ED indicators. Even participants with relatively few concussion symptoms (ie, those in the second quartile) had significantly elevated odds of reporting low testosterone levels compared with men in the lowest quartile.

Our findings add to a literature composed of studies linking single head injuries with pituitary dysfunction in the general population,^[@noi190068r6],[@noi190068r9],[@noi190068r10],[@noi190068r11]^ small studies of professional boxers,^[@noi190068r23],[@noi190068r24],[@noi190068r25],[@noi190068r26],[@noi190068r62],[@noi190068r63]^ and findings from veterans with blast-induced head injury,^[@noi190068r27],[@noi190068r28],[@noi190068r29]^ indicating that mechanical and blast-induced trauma may have associations with pituitary and sexual function. To our knowledge, this is the first large study to examine low testosterone levels and ED, albeit indirectly, in a nonclinical population with a high prevalence of repeated injuries. This is also the first study to adjust for risk factors such as BMI.

Several hypothesized mechanisms, including concussion-associated hypopituitarism, may explain the associations of concussion with low testosterone levels and ED. The pituitary gland is perfused by long portal vessels branching off the internal carotid artery,^[@noi190068r64]^ making it susceptible to mechanical trauma, low cerebral blood flow, and increased intracranial pressure associated with head injury.^[@noi190068r65],[@noi190068r66]^ Acceleration and deceleration forces can shear axonal tracts that connect the pituitary to the hypothalamus. Thus, the combination of intracranial pressure, reduced blood flow, and diffuse axonal injury between the pituitary and the hypothalamus could cause diminished pituitary function, leading to low testosterone levels and ED. In exploratory mediation analyses, we found that adjusting for current prescription pain medication use and sleep apnea modestly attenuated the association of concussion symptoms with low testosterone levels and ED. These results suggest that pain medication and sleep apnea should be explored as possible pathways through which head injury affects hormone levels and sexual function.

Limitations {#H2-6-NOI190068}
-----------

Our study has several limitations. First, we used indirect measures of low testosterone levels and ED. However, participant-reported health care clinician medication recommendations may be reasonable proxies: self-reported sexual dysfunction single-question assessments^[@noi190068r67],[@noi190068r68]^ have largely replaced invasive physiological tests in clinical and research settings.^[@noi190068r69],[@noi190068r70],[@noi190068r71]^ Medical records, often a criterion standard for case ascertainment for other outcomes, may be less reliable for sexual dysfunction given that only 30% of men seek medical treatment for ED.^[@noi190068r72]^ Nevertheless, US men are comparatively more likely to seek treatment vs men in European countries (56% vs 10%-47%) and more willing to take ED medication.^[@noi190068r73]^ Moreover, the validity of our indicators is supported by statistically significant associations with known low testosterone and ED risk factors and by sensitivity analyses in men who self-reported currently using testosterone therapy and ED medication.

Second, concussion data were collected retrospectively, raising the possibility of recall bias. However, the robust monotonic association of the concussion exposure with the outcomes suggests simple recall bias may not solely account for our findings. Third, the concussion symptom scale has not been validated. To our knowledge, there is no validated retrospective measure of concussion symptoms. In our data, findings were similar using LOC count.^[@noi190068r53],[@noi190068r54],[@noi190068r74],[@noi190068r75]^ Moreover, simpler metrics, such as the number of diagnosed concussions, may not adequately capture the experience of concussion or concussion severity; at least 30% of concussions may be undiagnosed,^[@noi190068r21],[@noi190068r75],[@noi190068r76]^ players may hide concussions,^[@noi190068r21]^ and concussion management during professional play has changed over time.^[@noi190068r45]^ Concussion symptoms have been used previously as a surrogate for head injury exposure and severity.^[@noi190068r77],[@noi190068r78],[@noi190068r79],[@noi190068r80]^

Fourth, we do not know whether low testosterone levels or ED preceded men's exposure to professional football. Fifth, the stigma surrounding sexual dysfunction could affect participants' likelihood of speaking to their health care clinician or responding honestly on the survey.^[@noi190068r81]^ However, this would only produce the results presented in this article if such under-reporting were less likely among men with more reported concussion symptoms. Sixth, bias from the relatively low participation rate could have affected our estimates,^[@noi190068r82]^ although statistically significant monotonic relationships persisted in inverse probability of participation--weighted analyses. Seventh, illicit drug use may affect low testosterone^[@noi190068r83],[@noi190068r84]^ and ED^[@noi190068r85]^; however, we did not query illicit drug use. Finally, health status may have been associated with players' decisions to participate: the healthiest players may have been less motivated to participate and the players with the most impairment may have been unable to participate.^[@noi190068r82]^ However, measures of association would be biased only if participation was concurrently associated with the exposure (concussion symptoms) and the outcome (low testosterone levels or ED).^[@noi190068r86]^

Conclusions {#H1-5-NOI190068}
===========

This study's data suggest that concussion symptoms experienced during playing years may place NFL players at risk of low testosterone levels and ED decades later. These findings have implications for civilians and veterans who have experienced head injury, as well as for participants in combative and contact sports (eg, mixed martial arts, hockey, boxing, and soccer) who may experience repeated head trauma. Replication of our findings among nonprofessional football players and in the general population is a critical next step. Treatments for testosterone insufficiency and ED, including testosterone replacement therapy and phosphodiesterase type 5 inhibitors, are generally considered safe and have high efficacy rates.^[@noi190068r87],[@noi190068r88],[@noi190068r89]^ Our results could encourage clinicians to proactively query these treatable outcomes in patients with brain injuries as well as motivate future longitudinal studies to increase our understanding of the causal association between concussion and low testosterone levels and ED.

###### 

eTable**.**Odds ratios and 95% confidence intervals (CI) for players reporting low testosterone indicator only (Model 1), players reporting ED indicator only (Model 2), or players reporting both low testosterone and ED indicators (Model 3) compared to players reporting neither outcome. All models are age- and race-adjusted. Results are shown for each quartile of concussion symptom score where the lowest quartile serves as the reference group.

###### 

Click here for additional data file.
